insights_auto
Why is MANKIND down ३.०७%?
Dive Deeperchevron_right
MANKIND:NSE
म्यानकाइन्ड फार्मा
₹ २,२७५.५०
arrow_downward
-३.०७%(-७२.१०) 1D
अक्टोबर १६, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MANKIND...
Open
₹ २,३४९.९०
High
₹ २,३५४.४०
Low
₹ २,२६८.७०
Mkt. cap
९.३७ खरब
Avg. vol.
४.८४ लाख
Volume
८.९० लाख
P/E ratio
४६.०४
52-wk high
₹ २,६४२.००
52-wk low
₹ १,९०९.७०
EPS
₹ ४९.४२
No. of employees
२० हजार
Open
₹ २,३४९.९०
High
₹ २,३५४.४०
Low
₹ २,२६८.७०
Mkt. cap
९.३७ खरब
Avg. vol.
४.८४ लाख
Volume
८.९० लाख
P/E ratio
४६.०४
52-wk high
₹ २,६४२.००
52-wk low
₹ १,९०९.७०
EPS
₹ ४९.४२
No. of employees
२० हजार
News stories
From web sources and news partners
Simply Wall Street
·
५० मिनेट पहिले
Freshworks (FRSH) Shares Just Moved, So What Is Going On?
KuCoin
·
४० मिनेट पहिले
Nasdaq posts its worst weekly decline since June, gold rebounds but faces resistance at 4200
Yahoo Finance
·
१४ घण्टा पहिले
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
MarketWatch
·
१ दिन पहिले
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About म्यानकाइन्ड फार्मा
CEORajeev Juneja | Sheetal Arora
Employees२०.५ हजार
Founded१९९१
Headquarters-
Sector-
Websitemankindpharma.com